Merck Warns Physicians to Stop Prescribing the Cholesterol Pill Tredaptive

Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .
Harvard Medical School
.
Chrome 2001
Chrome 2001
.

Merck Warns Physicians to Stop Prescribing the Cholesterol Pill Tredaptive

Drug Resource Center
8124
Medications
Merck Warns Physicians to Stop Prescribing the Cholesterol Pill Tredaptive
Merck Warns Physicians to Stop Prescribing the Cholesterol Pill Tredaptive
canadianp_eng_2013_01_11_eng-canadianp_business_eng-canadianp_business_110118_88
(Canadian Press) -- Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
1470967
InteliHealth
2013-01-11
t
General Health News
2013-02-10
.
Merck Warns Physicians to Stop Prescribing the Cholesterol Pill Tredaptive
January 11, 2013

(Canadian Press) -- Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.

Tredaptive is available in about 70 countries, including Europe. The drug is not approved in the United States.

Merck last month said initial results from a late-stage study showed that adding Tredaptive to traditional statin therapy did not lower the risk of heart attack, stroke and related problems.

Results also showed that patients taking the cholesterol combination pill were more likely to suffer some serious, non-fatal adverse events.

Merck says it made its decision based in part on a European Medicine Agency committee recommendation.

Merck has advised patients to quit taking the drug only after talking to a physician.

(c) The Canadian Press, 2013

.  
341, 8011, 20779, 21291,
cholesterol,drug
21291
Last updated January 11, 2013


    Print Printer-friendly format    
   
.
.  
This website is certified by Health On the Net Foundation. Click to verify.
.